Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T18:58:43.527Z.
Calculation as of: 2026-10-06T18:58:43.527Z.
Quote observation: 2026-10-06T18:55:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 05c00b329f1e3adc6cfa9751fac96b44e9956e0cda8839801cbe896438e656e1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-08-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Syndax Pharmaceuticals, Inc.
Market Cap
$1.54B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
Price/OCF Ratio
N/A
TTM Avg
27.23
3Y Avg
27.23
5Y Avg
27.23
Market Cap
$1.51B
Price/OCF Ratio
99.52
TTM Avg
58.20
3Y Avg
417.88
5Y Avg
357.25
Market Cap
$1.49B
Price/OCF Ratio
21.54
TTM Avg
21.79
3Y Avg
15.72
5Y Avg
18.04
Market Cap
$1.61B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.47B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.54B | N/A | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 8.06 | 9.12 | 8.67 | 7.22 |
| Nutex Health, Inc. (NUTX)vs › | $1.52B | 5.44 | 5.17 | 9.74 | 17.18 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | N/A | 27.23 | 27.23 | 27.23 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 99.52 | 58.20 | 417.88 | 357.25 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 21.54 | 21.79 | 15.72 | 18.04 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 8.83 | 11.82 | 9.67 | 19.67 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2022-08-08 | 146.29 |
| 2022-08-05 | 143.82 |
| 2022-08-04 | 136.77 |
| 2022-08-03 | 126.46 |
| 2022-08-02 | 123.27 |
| 2022-08-01 | 122.79 |
| 2022-07-29 | 122.73 |
| 2022-07-28 | 127.37 |
| 2022-07-27 | 127.91 |
| 2022-07-26 | 126.52 |
| 2022-07-25 | 127.61 |
| 2022-07-22 | 125.08 |
| 2022-07-21 | 119.66 |
| 2022-07-20 | 115.14 |
| 2022-07-19 | 115.56 |
| 2022-07-18 | 113.39 |
| 2022-07-15 | 114.72 |
| 2022-07-14 | 115.32 |
| 2022-07-13 | 115.56 |
| 2022-07-12 | 114.23 |
| 2022-07-11 | 111.52 |
| 2022-07-08 | 117.07 |
| 2022-07-07 | 119.11 |
| 2022-07-06 | 122.73 |
| 2022-07-05 | 122.73 |
| 2022-07-01 | 114.90 |
| 2022-06-30 | 115.92 |
| 2022-06-29 | 114.96 |
| 2022-06-28 | 111.64 |
| 2022-06-27 | 112.73 |
| 2022-06-24 | 115.26 |
| 2022-06-23 | 114.41 |
| 2022-06-22 | 106.64 |
| 2022-06-21 | 105.26 |
| 2022-06-17 | 101.46 |
| 2022-06-16 | 95.26 |
| 2022-06-15 | 97.79 |
| 2022-06-14 | 94.89 |
| 2022-06-13 | 93.99 |
| 2022-06-10 | 98.63 |
| 2022-06-09 | 103.39 |
| 2022-06-08 | 106.64 |
| 2022-06-07 | 102.18 |
| 2022-06-06 | 96.28 |
| 2022-06-03 | 99.29 |
| 2022-06-02 | 100.01 |
| 2022-06-01 | 99.83 |
| 2022-05-31 | 99.41 |
| 2022-05-27 | 98.33 |
| 2022-05-26 | 91.46 |
| 2022-05-25 | 88.27 |
| 2022-05-24 | 85.37 |
| 2022-05-23 | 87.72 |
| 2022-05-20 | 88.33 |
| 2022-05-19 | 83.27 |
| 2022-05-18 | 82.18 |
| 2022-05-17 | 88.15 |
| 2022-05-16 | 84.47 |
| 2022-05-13 | 85.01 |
| 2022-05-12 | 84.05 |
| 2022-05-11 | 83.14 |
| 2022-05-10 | 91.22 |
| 2022-05-09 | 27.58 |
| 2022-05-06 | 29.35 |
| 2022-05-05 | 30.32 |
| 2022-05-04 | 31.96 |
| 2022-05-03 | 31.51 |
| 2022-05-02 | 31.38 |
| 2022-04-29 | 30.61 |
| 2022-04-28 | 30.89 |
| 2022-04-27 | 29.85 |
| 2022-04-26 | 29.75 |
| 2022-04-25 | 30.56 |
| 2022-04-22 | 29.97 |
| 2022-04-21 | 30.43 |
| 2022-04-20 | 31.34 |
| 2022-04-19 | 31.00 |
| 2022-04-18 | 31.38 |
| 2022-04-14 | 33.11 |
| 2022-04-13 | 33.53 |
| 2022-04-12 | 31.93 |
| 2022-04-11 | 32.33 |
| 2022-04-08 | 31.96 |
| 2022-04-07 | 34.35 |
| 2022-04-06 | 34.98 |
| 2022-04-05 | 35.56 |
| 2022-04-04 | 34.90 |
| 2022-04-01 | 32.16 |
| 2022-03-31 | 31.73 |
| 2022-03-30 | 31.49 |
| 2022-03-29 | 33.31 |
| 2022-03-28 | 31.63 |
| 2022-03-25 | 32.13 |
| 2022-03-24 | 32.51 |
| 2022-03-23 | 32.13 |
| 2022-03-22 | 32.86 |
| 2022-03-21 | 30.94 |
| 2022-03-18 | 30.50 |
| 2022-03-17 | 30.67 |
| 2022-03-16 | 31.16 |
| 2022-03-15 | 29.35 |
| 2022-03-14 | 28.79 |
| 2022-03-11 | 30.76 |
| 2022-03-10 | 31.91 |
| 2022-03-09 | 31.60 |
| 2022-03-08 | 31.03 |
| 2022-03-07 | 30.06 |
| 2022-03-04 | 27.84 |
| 2022-03-03 | 29.37 |
| 2022-03-02 | 29.41 |
